Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170 | 36 | 0 | 11 | N/A |
| Receivables | 50 | N/A | N/A | 10 | N/A |
| Inventories | N/A | N/A | N/A | 6 | N/A |
| TOTAL | $220 | $36 | $0 | $27 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 25 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $25 | $N/A |
| Total Assets | $220 | $36 | $0 | $52 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 168 | 34 | 1 | 231 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 27 | N/A |
| Other current liabilities | N/A | N/A | N/A | 5 | N/A |
| TOTAL | $1,019 | $262 | $1 | $342 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,019 | $262 | $1 | $342 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,026 | 85,104 | 105,416 | N/A | N/A |
| Common Shares | 87 | 85 | 85 | 28 | N/A |
| Retained earnings | -2,241 | -383 | -86 | -13,883 | N/A |
| TOTAL | $-799 | $-225 | $-1 | $-291 | $N/A |
| Total Liabilities And Equity | $220 | $36 | $0 | $52 | $0 |